XML 199 R94.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information - Reconciliation of Adjusted EBITDA to Income (Loss) from Continuing Operations (Details) - USD ($)
$ in Thousands
 12 Months Ended 27 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2021
Reconciliation of Adjusted EBITDA to income from continuing operations        
Income (Loss) from Continuing Operations $ 452,725 $ 343,096 $ 268,211  
Interest expense, net 417,961 418,535 419,298  
Provision (Benefit) for Income Taxes 176,290 29,609 59,931  
Depreciation and amortization 680,422 652,069 658,201  
Acquisition and Integration Costs 12,764 0 13,293  
Restructuring charges 206,426 194,396 48,597 $ 449,419
Intangible impairments 0 23,000 0  
(Gain) loss on disposal/write-down of property, plant and equipment, net (including real estate) (172,041) (363,537) (63,824)  
Other (income) expense, net, excluding our share of losses (gains) from our unconsolidated joint ventures(1) (205,746) 133,611 25,720  
Stock-based compensation expense 61,001 34,272 36,194  
COVID-19 Costs 0 9,285 0  
Our share of Adjusted EBITDA reconciling items from our unconsolidated joint ventures 4,897 1,385 3,388  
Adjusted EBITDA $ 1,634,699 1,475,721 $ 1,469,009  
Cost of Sales        
Reconciliation of Adjusted EBITDA to income from continuing operations        
COVID-19 Costs   7,600    
Selling, general and administrative expenses        
Reconciliation of Adjusted EBITDA to income from continuing operations        
COVID-19 Costs   $ 1,600